(Total Views: 190)
Posted On: 08/16/2017 8:18:05 AM
Post# of 72446
He's no friend of mine. Just saying the high end of his valuation range is likely what we will be dealing with for Prurisol if we strike a deal after this trial.
$50-$100M upfront, $200-$300M milestones to approval with mid 20% royalties. That's assuming sound confirmation of the percentages we saw in P2A. Could be upside or downside from there. Nobody knows except the IPIX team.
A deal on those terms sends our stock to $10 over night.
Go IPIX!
$50-$100M upfront, $200-$300M milestones to approval with mid 20% royalties. That's assuming sound confirmation of the percentages we saw in P2A. Could be upside or downside from there. Nobody knows except the IPIX team.
A deal on those terms sends our stock to $10 over night.
Go IPIX!
(1)
(0)
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
